Drugs / SABER-Bupivacaine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00993798 | Apr 2009 → Jun 2011 | — | Durect | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02574520 Comparator | Nov 2015 → Jun 2017 | — | Durect | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SABER-Bupivacaine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00993798 ↗ |